Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
August 26, 2021 at 09:03 am
Share
Tianjin Ringpu Bio-Technology Co.,Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 1,040.707 million compared to CNY 924.328 million a year ago. Operating income was CNY 255.142 million compared to CNY 199.782 million a year ago. Net income was CNY 203.585 million compared to CNY 147.297 million a year ago. Basic earnings per share from continuing operations was CNY 0.5127 compared to CNY 0.3729 a year ago.
TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD is a China-based company principally involved in the research, development, manufacture and sales of biological products and preparations for veterinary uses. The Company operates through two main segments. The Veterinary Use Biological Products segment is mainly involved in the manufacture and sales of poultry vaccines, veterinary use vaccines, biological products for treatment, diagnostic products and other biological products. The Veterinary Preparations segment is mainly involved in the manufacture and sales of chemical preparations, veterinary Chinese medicine and other preparations.